Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Increase in Online Prescriptions During COVID-19 Pandemic

Key Points: Traditional pharmacy services make getting prescriptions complicated. Pharmacies turned to online models during the pandemic. Pharmaserve allows customers to get their prescriptions filled online. Commentary: Getting your prescription medication can be a pain, especially when it requires you to go into a pharmacy to go and get it. But more options are…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Increase in Online Prescriptions During COVID-19 Pandemic

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Key Points:

  • Traditional pharmacy services make getting prescriptions complicated.
  • Pharmacies turned to online models during the pandemic.
  • Pharmaserve allows customers to get their prescriptions filled online.

Commentary:

Getting your prescription medication can be a pain, especially when it requires you to go into a pharmacy to go and get it. But more options are starting to appear like Pharmaserve, a Canadian-based online pharmaceutical platform that allows consumers to get their prescriptions refilled online rather than having to stand in line at your local pharmacy. We asked Seun Bammeke, Managing Director of Pharmaserve, how they have been able to manage the pain in the process of buying prescription pills online. Like everything in the past year and a half, online versions of anything have become more popular. We also asked Bammeke how the hyper-focus of making everything socially distant or contact-free helped speed up users’ adoption of their services.

Abridged Thoughts:

We sell and ship prescription medication to the United States, so there are typically often many pain points. However, we’ve been able to eliminate a lot of them for our customers. So, for example, since we do not have a physical location, our costs are substantially less than your typical brick and mortar brick and mortar pharmacy apologies. And so, because of that, we are able to pass on a lot of the savings directly onto our customers, which means they’re even cheaper medications for that.

Well, fortunately, the pharmacy has always been fully online. However, our customers’ adoption rate has increased dramatically due to the current world pandemic. We have proven to our patients and prospective patients, they’re able that we are able to provide them with a safe way of delivering their medications while ensuring that it is affordable to our patients. Companies throughout this pandemic have found ways to step up and fill in a void where it is needed and, in turn, made some even more successful or well known.

With Merck’s COVID Antiviral Announcement, Can the Pharma Pipeline Build Treatment Momentum?

What is Behind the “Mergers & Acquisitions” Boom in Healthcare?

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The healthcare industry faces significant consequences when delayed decision-making occurs. Prompt and efficient action is crucial to prevent adverse impacts on patient care and operational efficiency. Addressing this issue requires a commitment to more agile and informed decision processes.

  • 01Delayed decision-making in healthcare can lead to negative impacts on patient care and operational efficiency.
  • 02Healthcare organizations are encouraged to adopt agile decision-making processes to improve effectiveness.
  • 03Implementing informed and prompt decision-making strategies can mitigate the risks of inefficiencies and poor patient outcomes.

Aug 17, 2026

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

The Centers for Medicare & Medicaid Services (CMS) launched its tech-enabled chronic care pilot program, known as the ACCESS pilot. Despite its initiation, a significant issue persists as patients struggle to find which healthcare providers are participating in the program. Meanwhile, the FDA has authorized 115 AI-based medical devices in 2021.

  • 01CMS has initiated the ACCESS pilot program to enhance chronic care management using technology.
  • 02Patients are facing challenges in identifying healthcare providers involved in the ACCESS pilot.
  • 03In 2021, the FDA authorized 115 AI-based medical devices.

Aug 17, 2026

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

BioNTech has appointed Guido Oelkers, the current CEO of Sobi, as its next chief executive. Oelkers is tasked with advancing BioNTech's oncology pipeline to achieve multiple approved products by 2030.

  • 01BioNTech has selected Guido Oelkers as its new CEO, effective soon.
  • 02Guido Oelkers aims to turn BioNTech's deep oncology pipeline into several approved products by 2030.

Aug 17, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512